PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
26-Feb-2021 B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG Q1 '20/'21 Results B.R.A.I.N. Biotechnology Research And Information Network AG
26-Feb-2021 Polyphor to present full-year 2020 financial results on March 5 Polyphor AG
25-Feb-2021 Celonic to Boost its Cell & Gene Therapy Production with Facility in the Upcoming Life Science Park Rheintal in Stein, Switzerland B3C newswire
25-Feb-2021 Bayer delivers robust performance despite pandemic – foundation laid for future growth Bayer
25-Feb-2021 Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of Medicine Roche
25-Feb-2021 Bristol Myers Squibb Donates $11 Million to Advance Health Equity Bristol Myers Squibb
25-Feb-2021 Moderna Announces it has Shipped Variant-Specific Vaccine Candidate, mRNA-1273.351, to NIH for Clinical Study Moderna
25-Feb-2021 Teknova expands production capacity to meet demand for viral transport media Teknova
25-Feb-2021 PharmaLex broadens biopharma expertise PharmaLex
25-Feb-2021 Amryt Supports Global Rare Disease Day 2021 Amryt
25-Feb-2021 Verona Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update Verona Pharma
25-Feb-2021 Evolva reports Full Year Results for 2020, with significant increase in customer demand for Health Ingredients and product expansion Evolva Holding SA
24-Feb-2021 CrownBio and JSR Life Sciences Partner with Cambridge Quantum Computing to Leverage Quantum Machine Learning for Novel Cancer Treatment Biomarker Discovery CrownBio
24-Feb-2021 Nass Valley Gateway Ltd (NVG) Announces It Has Retained Former Kannaway CEO Jeff Rogers as Consultant Nass Valley Gateway Ltd.
24-Feb-2021 Locate Bio’s Chondro3 Granted FDA Breakthrough Device Designation Locate Bio
24-Feb-2021 University of Birmingham spinout secures £800k for point of care diagnostics platform Linear Diagnostics Ltd
24-Feb-2021 Gilead and Galapagos discontinuing IPF Phase III front-runner is a major setback in the disease space, says GlobalData Gilead and Galapagos
24-Feb-2021 Newton Biocapital invests in Flemish start-up DeuterOncology Newton Biocapital
24-Feb-2021 Toxys Strengthens Executive Team with Appointment of a CSO B3C newswire
24-Feb-2021 Release of results for the first quarter 2020/21 (ending 31 December 2020) on 26 February 2021 Douglas GmbH